SCHEMBL16168708

SCHEMBL16168708

Cc1ccc(O)c(C(C)C(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
CHRM1 P11229 4/20 0.52
ADRA1A P35348 3/20 0.52
TRPA1 O75762 2/20 0.52
SLC6A2 P23975 2/20 0.52
HTR2B P41595 2/20 0.52
TP53 P04637 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX15 P16050 4/20 0.45
HSD17B10 Q99714 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HRH1 P35367 3/20 0.44
MAPT P10636 2/20 0.44
CHRM2 P08172 2/20 0.44
CHRM5 P08912 2/20 0.44
CHRM3 P20309 2/20 0.44
ESR1 P03372 2/20 0.44
HTR2A P28223 2/20 0.44
OPRK1 P41145 2/20 0.44
CHRM4 P08173 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50784 0.82 LMNA (0.56) LMNACHRM1ADRA1ATRPA1SLC6A2
Isothymol SCHEMBL852892 0.82 LMNA (0.68) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL7758863 0.80 LMNA (0.54) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL13257345 0.79 TRPA1 (0.56) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL24299898 0.78 LMNA (0.52) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL11075829 0.78 KDM4E (0.47) LMNACHRM1ADRA1ATRPA1SLC6A2
Isothymol SCHEMBL11039381 0.78 LMNA (0.63) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL9198019 0.78 LMNA (0.52) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL23049815 0.77 ALDH1A1 (0.41) LMNACHRM1ADRA1ATRPA1SLC6A2
SCHEMBL218020 0.77 TRPA1 (0.54) LMNACHRM1ADRA1ATRPA1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332909-B1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LTD (GB) 2014-10-15 EP disclosed